Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.560
0.00 (0.00%)
At close: Mar 6, 2026, 4:00 PM EST
2.650
+0.090 (3.52%)
After-hours: Mar 6, 2026, 6:04 PM EST
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $459.90 million as of March 6, 2026. Its market cap has increased by 613.27% in one year.
Market Cap
459.90M
Enterprise Value
371.21M
1-Year Change
613.27%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $459.90M, a decrease of -56.24%. That is a compound annual growth rate of -16.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 459.90M | 429.48% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 480.35M |
| Kyverna Therapeutics | 479.32M |
| Lyell Immunopharma | 472.47M |
| Vanda Pharmaceuticals | 467.54M |
| vTv Therapeutics | 461.86M |
| Immix Biopharma | 450.02M |
| Lineage Cell Therapeutics | 445.88M |
| REGENXBIO | 441.43M |